Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Purdue Pharma appoints Dr Alan Dunton

He joins the pain specialist as senior VP of research and development

Lucid team : because you’re worth it!

Lucid group reward the team for an amazing year

Lucid Group Communications Limited

- PMLiVE

Novo Nordisk says Victoza outperforms SGLT2 inhibitors

Comparesthe GLP-1 agonist to Invokana, Jardiance and Farxiga

EISAI

Eisai expands in China with generics company acquisition

BuysLiaoning TianYi Biological Pharmaceutical

Second patient death in Zafgen’s obesity drug trial

Furtherblood clot incident seen after FDA hit study with a clinical hold

- PMLiVE

Why is behaviour change so difficult? By Patrick Ladbury, Communications Manager at the National Social Marketing Centre.

Patrick Ladbury nudges us to overcome the barriers to behaviour change. Read on to find out.

Say Communications

Ablynx appoints Robert Zeldin chief medical officer

He previously servedat Merck & Co, Novartis and the FDA

- PMLiVE

Express Scripts to offer alternative to Turing’s Daraprim

Andpromises to share compounded formulation with other healthcare payers

- PMLiVE

Pfizer’s Xalkori approved for wider use in Europe

Labelupdate gives the lung cancer therapy a new first-line indication

EU flag

Second biosimilar anti-TNF nears EU market

SamsungBioepis' version of Enbrel recommended for approval by the CHMP

Roche - Basel

Roche drops superbug partnership with Polyphor

But adds inflammation research agreement with Proximagen

- PMLiVE

Langland and CAHG take top prizes at Best of Health Awards

Pick up Gold Apples as the IPA awards celebratestheir 20th anniversary

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links